Trials / No Longer Available
No Longer AvailableNCT07223606
Fecal Microbiota Transplant for Neuroblastoma in a Single Patient
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- ProgenaBiome · Academic / Other
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- Not accepted
Summary
This study uses fecal microbiota transplant (FMT) to correct gut microbiome dysbiosis prior to and during standard-of-care neuroblastoma treatment
Detailed description
Patients with neurobastoma and concurrent dysbiosis showing a bifidobacteria-bacteroides gap will undergo fecal microbiota transplant as an adjunctive to standard-of-care oncology treatment.
Conditions
- Neuroblastoma
- Neuroblastoma (NB)
- Neuroblastoma (NBL)
- Neuroblastoma (Measurable Disease)
- Neuroblastoma Recurrent
- Neuroblastoma in Children
- Neuroblastoma. CNS
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Fecal Microbial Transplantation | This study will utilize donor stool from an infant |
Timeline
- First posted
- 2025-11-03
- Last updated
- 2025-11-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07223606. Inclusion in this directory is not an endorsement.